Iovance Biotherapeutics Price Forecast Slashed By 40% On Mutated Uptake For Its Newly Approved Skin Cancer Cell Therapy

Piper Sandler downgraded Iovance Biotherapeutics Inc IOVA, citing the slow launch of Amtagvi (lifileucel), a prescription medicine used to treat adults with a type of skin cancer that cannot be removed surgically or has spread to other parts of the body called unresectable or metastatic melanoma. Amtagvi is made from surgically removed tumor. Tumor-derived T cells are grown in a manufacturing center. Piper Sandler spoke with six authorized treatment centers (ATCs) to gauge the early utilization of Amtagvi. ...